Nasha Zhang

2.9k total citations · 1 hit paper
68 papers, 1.9k citations indexed

About

Nasha Zhang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nasha Zhang has authored 68 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 36 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nasha Zhang's work include Cancer-related molecular mechanisms research (33 papers), RNA modifications and cancer (28 papers) and RNA Research and Splicing (15 papers). Nasha Zhang is often cited by papers focused on Cancer-related molecular mechanisms research (33 papers), RNA modifications and cancer (28 papers) and RNA Research and Splicing (15 papers). Nasha Zhang collaborates with scholars based in China, United States and United Kingdom. Nasha Zhang's co-authors include Ming Yang, Ling Wei, Xingwu Wang, Liyan Lv, Yan Zheng, Yue Shen, Yeyang Xu, Jiandong Liu, Yemei Song and Jibing Liu and has published in prestigious journals such as Journal of Biological Chemistry, ACS Nano and PLoS ONE.

In The Last Decade

Nasha Zhang

67 papers receiving 1.9k citations

Hit Papers

Noncoding RNAs in gastric cancer: implications for drug r... 2020 2026 2022 2024 2020 100 200 300

Peers

Nasha Zhang
Song Hu China
Yi Bao China
Junjeong Choi South Korea
Xi Liu China
Bing Chen China
Nasha Zhang
Citations per year, relative to Nasha Zhang Nasha Zhang (= 1×) peers Jundong Zhou

Countries citing papers authored by Nasha Zhang

Since Specialization
Citations

This map shows the geographic impact of Nasha Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasha Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasha Zhang more than expected).

Fields of papers citing papers by Nasha Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasha Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasha Zhang. The network helps show where Nasha Zhang may publish in the future.

Co-authorship network of co-authors of Nasha Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Nasha Zhang. A scholar is included among the top collaborators of Nasha Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasha Zhang. Nasha Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Wenjuan, Yinggang Sun, Yanting Yang, et al.. (2025). Non-coding RNAs in gastric cancer: mechanisms and therapeutic prospects. Molecular Cancer. 24(1). 244–244. 1 indexed citations
3.
Yang, Yanting, Zongcheng Li, Xinyuan Yu, et al.. (2025). WDR11-DT enhances radiosensitivity via promoting PARP1 degradation and homologous recombination deficiency. Cancer Letters. 625. 217757–217757. 2 indexed citations
5.
Liu, Wenjuan, et al.. (2024). Circular RNAs in lung cancer: implications for preventing therapeutic resistance. EBioMedicine. 107. 105309–105309. 7 indexed citations
6.
Ma, Chi, Nasha Zhang, Teng Wang, et al.. (2023). Inflammatory cytokine-regulated LNCPTCTS suppresses thyroid cancer progression via enhancing Snail nuclear export. Cancer Letters. 575. 216402–216402. 12 indexed citations
7.
Liu, Wenjuan, et al.. (2023). Long non-coding RNAs in non-small cell lung cancer: implications for preventing therapeutic resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(6). 188982–188982. 7 indexed citations
8.
Su, Tao, Jiandong Liu, Nasha Zhang, et al.. (2023). New insights on the interplays between m6A modifications and microRNA or lncRNA in gastrointestinal cancers. Frontiers in Cell and Developmental Biology. 11. 1157797–1157797. 6 indexed citations
9.
Wang, Teng, et al.. (2023). The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization. Pharmacogenomics and Personalized Medicine. Volume 16. 229–238. 1 indexed citations
10.
Zhang, Nasha, et al.. (2023). Super Enhancer–Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis. Cancer Research. 83(24). 4080–4094. 44 indexed citations
11.
Zhang, Nasha, et al.. (2022). CircPDIA4 Induces Gastric Cancer Progression by Promoting ERK1/2 Activation and Enhancing Biogenesis of Oncogenic circRNAs. Cancer Research. 83(4). 538–552. 64 indexed citations
13.
Song, Yemei, Yeyang Xu, Yue Shen, et al.. (2020). Identification of Leukocyte telomere length-related genetic variants contributing to predisposition of Esophageal Squamous Cell Carcinoma. Journal of Cancer. 11(17). 5025–5031. 6 indexed citations
14.
Wu, Jia, Nasha Zhang, Fei Han, et al.. (2019). Integrating Tumor and Nodal Imaging Characteristics at Baseline and Mid-Treatment Computed Tomography Scans to Predict Distant Metastasis in Oropharyngeal Cancer Treated With Concurrent Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. 104(4). 942–952. 23 indexed citations
15.
Zhang, Nasha, Yan Zheng, Li Zhang, et al.. (2018). miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs. Laboratory Investigation. 99(4). 568–576. 31 indexed citations
16.
17.
Qiu, Xiaoguang, Yidong Chen, Jupeng Yuan, et al.. (2018). Functional BCL-2 rs2279115 Promoter Noncoding Variant Contributes to Glioma Predisposition, Especially in Males. DNA and Cell Biology. 38(1). 85–90. 20 indexed citations
18.
Zhang, Nasha, et al.. (2018). Leukocyte telomere length and risk of gastric cardia adenocarcinoma. Scientific Reports. 8(1). 14584–14584. 8 indexed citations
19.
Yuan, Jupeng, Nasha Zhang, Hui Zhu, et al.. (2017). Clinical Implications of the Autophagy Core Gene Variations in Advanced Lung Adenocarcinoma Treated with Gefitinib. Scientific Reports. 7(1). 17814–17814. 24 indexed citations
20.
Yuan, Jupeng, Nasha Zhang, Hui Zhu, et al.. (2017). CHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer. Scientific Reports. 7(1). 11802–11802. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026